ASML's Record 2025: Is the 2026 Guidance Already Priced In?

ASML's 2025 performance was nothing short of spectacular. The company posted record total net sales of €32.7 billion and net income of €9.6 billion. The fourth quarter capped the year with a particularly strong showing, delivering record total net sales of €9.7 billion and a robust gross margin of 52.2%. This operational excellence, coupled with a staggering Q4 net bookings of €13.2 billion and a backlog that swelled to €38.8 billion, provided a powerful foundation for the future.

The core question now is whether the market's current optimism already reflects the bullish outlook. The company's own 2026 guidance sets a high bar, projecting total net sales between €34 billion and €39 billion. That top-end figure implies growth of nearly 19% from 2025, a trajectory that is already priced in as the key driver for the stock's rally. Analysts have moved in lockstep, with firms like Morgan Stanley, UBS, and JPMorgan raising price targets and maintaining a consensus Buy rating. The setup is clear: the market is betting heavily on this growth path.

Yet this very optimism creates a vulnerability. The stock has already surged nearly 30% year-to-date, a move that has priced in a significant portion of the anticipated success. When a company delivers a record year and then provides guidance that is itself bullish, the risk of a "sell the news" event increases. The market's expectations have been raised to a new level, leaving limited room for the 2026 results to simply meet them. The guidance gap, therefore, isn't about the numbers themselves, but about whether they can exceed the already-elevated expectations that have driven the stock higher.

The Backlog and Growth Drivers: High Expectations

The fundamental drivers behind ASML's bullish 2026 guidance are clear and powerful. The company enters the year with a backlog of €38.8 billion, a figure that provides exceptional revenue visibility. This backlog is not just a number; it is the direct result of a surge in demand, evidenced by record fourth-quarter net bookings of €13.2 billion, more than double the prior quarter. A staggering €7.4 billion of that Q4 bookings figure came from EUV systems, the company's most advanced and profitable technology. This combination of a massive order book and a recent spike in new orders sets a high bar for execution in 2026.

The growth is being fueled by two major secular trends. First, there is sustained, AI-related capital expenditure from key customers like TSMC, which has committed over USD 12.3 billion for its EUV tool fleet. Second, a strong DRAM cycle is providing additional demand. Together, these forces are projected to drive the broader EUV lithography market to reach $40.54 billion by 2031, growing at a 9.35% compound annual rate. This market expansion provides a solid long-term foundation for ASML's core business.

The next major growth vector is already on the horizon: High-NA EUV. This next-generation technology, with each system priced at approximately $380 million, is critical for advancing to nodes like 1.4 nm and 1 nm. While adoption is still transitioning from concept to practice, with companies like Intel and Samsung beginning deliveries, it represents the next significant revenue stream. The market is pricing in this future growth, as reflected in the consensus view that ASML's earnings expectations for 2026 and 2027 are already approximately 25% higher than the market consensus.

The bottom line is that the guidance is not pulled from thin air. It is built on a massive backlog, robust near-term demand, and a clear path to next-generation technology. The market has correctly identified these drivers and is already betting on them. The risk is not that the growth story is flawed, but that the stock's nearly 30% year-to-date rally has already priced in a significant portion of this optimistic trajectory.

The Risks and Second-Level Thinking

The bullish consensus view is built on powerful, tangible drivers. Yet for all its strength, the setup contains vulnerabilities that a second-level thinker must weigh. The primary near-term risk is a material decoupling from the Chinese market. Export controls have already begun to bite, and the potential for further restrictions or tariffs represents a "Grey Swan" event for ASML. While the company has a diversified global footprint, any significant, sustained decline in revenue from China would directly pressure the ambitious 2026 sales guidance. The market's optimism assumes this headwind is manageable, but it is a real and persistent uncertainty that could disrupt the growth trajectory.

Execution risk is the second major overhang. Converting a backlog of €38.8 billion into sales at the projected pace and margin is a monumental task. The complexity and cost of next-generation High-NA EUV systems, each priced at approximately $380 million, introduce new layers of operational risk. These are not simple production runs; they require flawless engineering and coordination with a limited number of customers. Any delays or cost overruns in this transition could pressure margins and slow the anticipated ramp in high-margin revenue.

The company's capital return strategy, including a new share buyback program of up to €12 billion, signals confidence and returns value to shareholders. However, this aggressive program also tightens the cash flow required for R&D and operations. In a high-valuation environment, the stock leaves little room for error. The market is pricing in a smooth, high-growth path. If execution falters even slightly on the backlog conversion or if the Chinese headwind proves more severe than anticipated, the risk/reward ratio shifts. The rally has already priced for perfection; the coming year will test whether reality can match it.

Catalysts and What to Watch

The path for ASML in 2026 is now defined by a series of near-term milestones. The first major test is the Q1 2026 report, where the company expects total net sales between €8.2 billion and €8.9 billion and a gross margin in the same 51% to 53% range as the full year. This quarter will be a critical signal. A result at the high end of that guidance would confirm the strong start to the year, while a miss would immediately challenge the bullish trajectory and could trigger a reassessment of the stock's valuation.

The primary metric to watch is the rate of backlog conversion. With a backlog of €38.8 billion, the company must execute flawlessly to hit its 2026 sales target. Any slowdown in the pace of converting those orders into revenue would be a red flag. Investors should also monitor for any shifts in customer capital expenditure plans, particularly from TSMC, whose 2026 capex is expected to increase to $52–$56 billion. Any deviation from that aggressive spending path would directly impact ASML's near-term order flow.

The most significant downside risk remains the Chinese market. While the company has diversified, any further tightening of export controls or the imposition of new tariffs represents a material threat. The market has priced in a smooth growth path, but the potential for a decoupling from China is a persistent uncertainty that could disrupt the guidance. Any update on this front, either through customer announcements or regulatory news, will be a key catalyst for volatility.

In summary, the catalysts are clear. The stock's nearly 30% year-to-date rally has priced in a successful 2026. The coming quarters will test whether reality can match that expectation. Watch Q1 sales and margins for early signs, track the backlog conversion rate, and remain vigilant for any shift in the geopolitical or customer capex landscape. The setup offers a high reward if execution is perfect, but the risk is that any stumble will be punished in a market that has already priced for perfection.